Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Mebea AKLILU"'
Publikováno v:
Chinese Journal of Lung Cancer, Vol 19, Iss 11, Pp 725-730 (2016)
Background and Objectives: Search for inexpensive laboratory markers have identified associations between blood counts and lung cancer outcomes. In this study, we evaluated the prognostic value of paraneoplastic leukocytosis (p-Leukocytosis) and para
Externí odkaz:
https://doaj.org/article/ce0ca026496b440da970087c0eb8e6c0
Autor:
Leigh C. Casadaban, Ajay V. Maker, Mebea Aklilu, Dana Villenes, Garth H. Rauscher, Sally Freels
Publikováno v:
Cancer. 122:3277-3287
BACKGROUND The role of adjuvant chemotherapy in patients with stage II colon cancer remains to be elucidated and its use varies between patients and institutions. Currently, clinical guidelines suggest discussing adjuvant chemotherapy for patients wi
Autor:
Sophie Dessureault, Vijaya Chadaram, Timothy M. Clay, Michael A. Morse, Donna Niedzwiecki, David S. Hsu, Mebea Aklilu, Robert Annechiarico, David Z. Chang, Christopher R. Garrett, David J. Cole, Takuya Osada, Mark W. Onaitis, Amy Hobeika, Todd S. Crocenzi, Bryan M. Clary, Anuradha Bulusu, John L. Marshall, H. Kim Lyerly, Gayathri R. Devi
Publikováno v:
Annals of Surgery. 258:879-886
To determine whether 1 of 2 vaccines based on dendritic cells (DCs) and poxvectors encoding CEA (carcinoembryonic antigen) and MUC1 (PANVAC) would lengthen survival in patients with resected metastases of colorectal cancer (CRC).Recurrences after com
Autor:
Anastasia Ivanova, A. William Blackstock, Joel E. Tepper, Bert H. O’Neil, Richard M. Goldberg, Janine M. Davies, Mebea Aklilu, Stephen A. Bernard, Laura Raftery
Publikováno v:
American Journal of Clinical Oncology. 36:250-253
Objectives Gemcitabine is a potent radiosensitizer. When combined with standard radiotherapy (XRT) the gemcitabine dose must be reduced to about 10% of its conventional dose. Oxaliplatin and erlotinib also have radiosensitizing properties. Oxaliplati
Autor:
George Yacoub, Chukwuemeka Ihemelandu, Matthew Graham, Greg Russell, Russell Howerton, Britt H. Bolemon, Mebea Aklilu, Edward A. Levine, Perry Shen
Publikováno v:
The American Surgeon. 79:414-421
Perioperative chemotherapy has been shown to improve disease-free survival compared with surgery alone for resectable colorectal liver metastases (CLM). We examined our experience with systemic chemotherapy in this clinical setting. A prospectively c
Autor:
Barbara J. Nicklas, George Yacoub, Nancy E. Avis, Mebea Aklilu, Gurjeet S. Birdee, Suzanne C. Danhauer, Stephanie J. Sohl
Publikováno v:
Complementary therapies in medicine. 25
Objectives Fatigue and other treatment-related symptoms (e.g., sleep disturbance) are critical targets for improving quality of life in patients undergoing chemotherapy. Yoga may reduce the burden of such symptoms. This study investigated the feasibi
Publikováno v:
Clinics in Colon and Rectal Surgery. 25:118-122
Colorectal cancer (CRC) is the second most common cancer in females and the third most common cancer diagnosed in males. Familial CRC comprises ~20 to 30% of all CRC cases. Lynch syndrome (LS), previously called hereditary nonpolyposis CRC (HNPCC), i
Autor:
James J. Urbanic, Thomas L. Ellis, James Lovato, D. Clay Cochran, Michael D. Chan, Natalie K. Alphonse, J. Daniel Bourland, Edward G. Shaw, Kevin P. McMullen, Stephen B. Tatter, Mebea Aklilu
Publikováno v:
Journal of Neurosurgery. 116:978-983
Object Gamma Knife surgery (GKS) has been reported as an effective modality for treating brain metastases from renal cell carcinoma (RCC). The authors aimed to determine if targeted agents such as tyrosine kinase inhibitors, mammalian target of rapam
Autor:
Mebea Aklilu, Cathy Eng
Publikováno v:
Nature Reviews Clinical Oncology. 8:649-659
Postoperative adjuvant chemoradiotherapy was recommended as the standard treatment for patients with rectal cancer because it reduces local recurrence. This paradigm shifted with the use of neoadjuvant chemoradiotherapy, which not only reduces local
Autor:
Greg Riedlinger, Paige B. Clark, Mebea Aklilu, Girish Mishra, Edward A. Levine, Kim R. Geisinger, Scott Isom, A. William Blackstock, Arta M. Monjazeb
Publikováno v:
Journal of Clinical Oncology. 28:4714-4721
Purpose To determine whether [18F]fluorodeoxyglucose positron emission tomography (FDG-PET) can delineate patients with esophageal cancer who may not benefit from esophagectomy after chemoradiotherapy. Patients and Methods We reviewed records of 163